( MENAFN - JCN NewsWire) FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the treatment of Early Alzheimer's disease LEQEMBI is the only ...

VMPL Hyderabad Telangana [India] January 13 CARE Hospitals one of India leading healthcare providers successfully treated a ...

We recently published an article titled These 10 Firms Led This Week’s Rally. In this article, we are going to take a look at ...

Acquisition expected to strengthen Stryker's neurovascular business with Inari VTE product portfolio including mechanical ...

Middle East and Asia Injectable Drugs market 2025 To achieve a therapeutic effect in humans and animals, drug delivery is the method of delivering a Pharmaceutical compound. Mr. Shah Coherent Market ...